NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

NASDAQ / LIVE COMPANY INTELLIGENCE

Cosmos Health Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCOSM
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / COSM COVERAGE

What’s moving Cosmos Health Inc. now

Current reporting with the operating signal separated from the noise.

01
Cosmos Health Inc.: Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

Cosmos Health Inc.: Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

The story matters when it changes Cosmos Health Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Cosmos Health Inc.: Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million ...

Cosmos Health Inc.: Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million ...

The story matters when it changes Cosmos Health Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Cosmos Health Inc Stock: Business Model, Growth Strategy, and Key Investor Considerations for North American Markets

Cosmos Health Inc Stock: Business Model, Growth Strategy, and Key Investor Considerations for North American Markets

Investors are testing whether Cosmos Health Inc.’s operating performance supports its strategy and valuation.

Watch next: official volume, pricing, inventory and segment margin.
04
Cosmos Health Inc. Enters U.S. Market with Strategic Manufacturing Partnership with DolCas Biotech

Cosmos Health Inc. Enters U.S. Market with Strategic Manufacturing Partnership with DolCas Biotech

The story matters when it changes Cosmos Health Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Greg Siokas Increases Stake in Cosmos Health Inc., Acquiring 1.47 Million Shares Worth $526,000

Greg Siokas Increases Stake in Cosmos Health Inc., Acquiring 1.47 Million Shares Worth $526,000

Investors are testing whether Cosmos Health Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest COSM filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-18 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-20 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-04-15 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-20 · Period 2026-08-19SEC ↗8-KMaterial company eventFiled 2026-07-16 · Period 2026-07-15SEC ↗8-KMaterial company eventFiled 2026-07-06 · Period 2026-06-30SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-02 · Period 2026-06-02SEC ↗NT 10-QOfficial SEC filingFiled 2026-08-14 · Period 2026-06-30SEC ↗
EARNINGS / QUARTERLY TRACKER

Cosmos Health Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.